Brief: Immunotech Biopharm Says Entered Into License Agreement With T-Cure

Immunotech Biopharm

12/01/2021 15:30

Jan 12 (Reuters) - Immunotech Biopharm Ltd  6978.HK :
    * ENTERED INTO LICENSE AGREEMENT WITH T-CURE
    * CO TO PAY UPFRONT PAYMENT OF US$2 MILLION, MILESTONE
PAYMENT OF
US$10 MILLION AND ROYALTIES
    * T-CURE TO GRANT EXCLUSIVE LICENSE TO CO TO USE T-CURE IP

Source text for Eikon:  ID:nHKS5QSMdV 
Further company coverage:  6978.HK 

 ((Reuters.Briefs@thomsonreuters.com;))